On this 1 February 2025, certain provisions of two European regulations will come into force for products placed on the market. Regulation (EU) 2024/858 bans 12 ingredients in nano form and imposes restrictions on the use of hydroxyapatite, while Regulation (EU) 2024/996 introduces restrictions on several endocrine disruptors and Arbutin.
Regulation (EU) 2024/858
Published on 15 March 2024, this Regulation comes into force on 1 February 2025 for products placed on the market.
Its provisions will apply from 1 November 2025 for products made available on the market.
12 nanos are banned
• Styrene/Acrylates Copolymer (nano)
• Sodium styrene/Acrylates Copolymer (nano)
• Copper (nano)
• Colloidal Copper (nano)
• Colloidal Silver (nano)
• Gold (nano)
• Colloidal Gold (nano)
• Gold Thioethylamino Hyaluronic Acid (nano)
• Acetyl Heptapeptide-9 Colloidal Gold (nano)
• Platinum (nano)
• Colloidal Platinum (nano)
• Acetyl Tetrapeptide-17 Colloidal Platinum (nano)
Hydroxyapatite (nano) is subject to restrictions
• Authorised only in toothpastes (maximum 10%) and mouthwashes (maximum 0.465%)
• Authorised only in the form of rod-shaped particles of which at least 95.8% (in particle number) have an aspect ratio less than 3, and the remaining 4.2% have an aspect ratio not exceeding 4.9, not coated or surface modified
• Prohibited in applications that may lead to exposure of the end-user’s lungs by inhalation
Regulation (EU) 2024/996
Published on 4 April 2025, this Regulation imposes restrictions on the use of several ingredients, which will apply from 1 February 2025 to products placed on the market.
The same provisions …
